Evidence map›Paper›PMID 31427909›Full record

ArticleContrast media & molecular imaging2019

Imaging Characteristics of USPIO Nanoparticles (<5 nm) as MR Contrast Agent

Xiaohong Ma, Shuang Wang, Longbin Hu, Shichao Feng, Zhiyuan Wu, Siyun Liu, Shaofeng Duan, Zhongwei Chen, Chunwu Zhou, Xinming Zhao

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. PEGylated Magnetite/Hydroxyapatite: A Green Nanocomposite for T2-Weighted MRI and Curcumin Carrying.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Review
  11. Emodin-Conjugated PEGylation of FeInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiaohong MaDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.ORCID 0000-0002-9048-8374
Shuang WangDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Longbin HuDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Shichao FengDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Zhiyuan WuState Key Laboratory of Molecular Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Siyun LiuGE Healthcare (China), Beijing 100176, China.
Shaofeng DuanGE Healthcare (China), Beijing 100176, China.
Zhongwei ChenGE Healthcare (China), Beijing 100176, China.
Chunwu ZhouDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Xinming ZhaoDiagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.ORCID 0000-0001-7286-771X
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron nanoparticles have an increasingly more and more important role in MR molecular imaging due to their novel magnetic and surface chemical properties. They provide new possibilities for noninvasive diagnosis and treatment monitoring, especially for tissues that are rich in macrophages. The smaller size and prolongation of the plasma half-life change the

Indexed as

Magnetic Resonance ImagingAnimalsBiocompatible MaterialsContrast MediaDextransFerric CompoundsHumansLiverMacrophagesMagnetite NanoparticlesRatsBiocompatible MaterialsContrast MediaDextransFerric Compoundsferric oxideferumoxtran-10Magnetite Nanoparticles

Identifiers

PMID31427909
PMCPMC6679865
OpenAlexW2963347365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.